Target intelligence / Profile preview

Severe acute respiratory syndrome coronavirus 2 virion (SARS-CoV-2 virion)

Target
SARS-CoV-2 virion
Molecular classification
Other (complete viral particle)
01

Overview

The SARS-CoV-2 virion is the complete, infectious unit of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[1][5]. It is a spherical particle, typically 60–140 nanometers in diameter, consisting of a lipid envelope embedded with structural proteins: spike (S), membrane (M), envelope (E), and nucleocapsid (N)[1][2][5]. The envelope encloses the positive-sense single-stranded RNA genome, coated by nucleocapsid (N) protein[1][5][3]. The spike (S) protein, a glycoprotein, mediates attachment to the human ACE2 receptor and membrane fusion, allowing viral entry into host cells[2][6][8]. The M protein shapes the virion and aids in assembly; the E protein plays a role in envelope formation and viral morphogenesis[1][4][5]. The overall architecture supports viral infection, propagation, and pathogenesis[1][5].

Other names
SARS-CoV-2 particleCOVID-19 virionnovel coronavirus virion
02

Biological functions

InfectionTransmissionPathogenesis
03

Disease associations

Infection (COVID-19)

Beyond the preview

Go deeper on Severe acute respiratory syndrome coronavirus 2 virion (SARS-CoV-2 virion).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Severe acute respiratory syndrome coronavirus 2 virion (SARS-CoV-2 virion).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call